STAT1-mediated translational control in tumor suppression and antitumor therapies

Shuo Wang1, Antonis E Koromilas2

  • 1Lady Davis Institute for Medical Research, McGill University, Sir Mortimer B. Davis-Jewish General Hospital , Montreal, Quebec, Canada.

Insights

Signal transducer and activator of transcription 1 (STAT1) acts as a tumor suppressor, paradoxically protecting cancer cells from DNA-damaging drugs. This involves STAT1 regulating mRNA translation for proteins with antitumor or prosurvival functions.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cellular signaling

Background:

  • Signal transducer and activator of transcription 1 (STAT1) exhibits dual roles in cancer.
  • STAT1 functions as a tumor suppressor but also confers resistance to chemotherapy.
  • Understanding STAT1's regulatory mechanisms is crucial for cancer therapy.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which STAT1 mediates its tumor suppressor and cytoprotective functions.
  • To investigate the role of STAT1 in regulating mRNA translation in cancer cells.
  • To identify specific mRNA targets influenced by STAT1.

Main Methods:

  • Analysis of STAT1-dependent gene expression.
  • mRNA translation assays.
  • Western blotting to assess protein levels.
  • Cell viability assays following DNA-damaging drug treatment.

Main Results:

  • STAT1 regulates the translation of specific mRNAs.
  • This translational control contributes to both tumor suppression and drug resistance.
  • STAT1 influences mRNAs encoding proteins with opposing functions (antitumor vs. prosurvival).

Conclusions:

  • STAT1 employs mRNA translation regulation as a key mechanism for its diverse roles in cancer.
  • Targeting STAT1-mediated translation could offer novel therapeutic strategies.
  • STAT1's dual function highlights the complexity of targeting transcription factors in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K